Medical Stocks To Research - July 30th

Key Points

• UnitedHealth Group, Hims & Hers Health, and Novo Nordisk A/S are highlighted as top medical stocks to research, with high trading volumes in recent days.
• UnitedHealth Group's stock has a market cap of $238.64 billion and traded at $263.07 with a P/E ratio of 10.98.
• Hims & Hers Health operates a telehealth platform, with shares trading at $65.76 and a market cap of $14.72 billion.

UnitedHealth Group, Hims & Hers Health, and Novo Nordisk A/S are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are publicly traded shares of companies operating in the healthcare sector—such as pharmaceutical firms, biotechnology developers, medical device manufacturers, and healthcare service providers. By buying these equities, investors seek exposure to the development of new drugs, treatments, and technologies aimed at improving patient outcomes. The value of medical stocks often hinges on factors like clinical trial results, regulatory approvals, patent lifecycles, and shifts in healthcare policy. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

UNH stock traded up $2.00 on Wednesday, hitting $263.07. The company's stock had a trading volume of 14,518,983 shares, compared to its average volume of 11,622,301. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group has a 1 year low of $248.88 and a 1 year high of $630.73. The stock has a market cap of $238.64 billion, a price-to-earnings ratio of 10.98, a price-to-earnings-growth ratio of 1.40 and a beta of 0.45. The firm has a 50 day moving average of $299.69 and a two-hundred day moving average of $421.43.

Read Our Latest Research Report on UNH

Hims & Hers Health (HIMS)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

NYSE HIMS traded up $5.49 during trading hours on Wednesday, reaching $65.76. The company's stock had a trading volume of 35,037,766 shares, compared to its average volume of 33,718,461. The stock has a market cap of $14.72 billion, a PE ratio of 95.16, a PEG ratio of 2.16 and a beta of 2.02. Hims & Hers Health has a fifty-two week low of $13.47 and a fifty-two week high of $72.98. The company's 50-day moving average is $53.06 and its two-hundred day moving average is $43.35.

Read Our Latest Research Report on HIMS

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

NYSE:NVO traded down $3.51 on Wednesday, reaching $50.44. The stock had a trading volume of 44,751,297 shares, compared to its average volume of 10,128,430. The company has a market cap of $225.19 billion, a price-to-earnings ratio of 14.90, a P/E/G ratio of 1.33 and a beta of 0.64. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.74 and a quick ratio of 0.56. The firm's fifty day moving average is $70.43 and its two-hundred day moving average is $73.37. Novo Nordisk A/S has a 12-month low of $50.02 and a 12-month high of $139.74.

Read Our Latest Research Report on NVO

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.